Nymox Pharmaceutical Corporation announced effective June 28, 2022, accepted the resignation of Erik Danielsen as Chief Financial Officer of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2169 USD | -1.37% | -15.60% | -63.24% |
1st Jan change | Capi. | |
---|---|---|
-63.24% | 20.54M | |
+32.44% | 50.85B | |
+0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.78% | 26.11B | |
-22.26% | 19.13B | |
+8.44% | 13.05B | |
+27.21% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Resignation of Erik Danielsen as Chief Financial Officer